He also recorded that he had come to know that Ranbaxy “management wanted the evidence destroyed”. Internal emails exchanged between Tsutomu Une, Ranbaxy Board chairman and Daiichi Sankyo’s points person in India, and Daiichi’s consultant Dick Van Duyne also reinforce the tribunal’s indictment. Present in the room were chairman Tejendra Khanna; Malvinder Singh, then president of pharmaceuticals and Ranbaxy’s owner; Brian Tempest, Chief Executive Officer (CEO); and top executives. Daiichi had purchased a majority stake in Ranbaxy from the Singh brothers and for Rs 19,804 crore on November, 2008. It culminated with Ranbaxy, under Daiichi, paying $500 m to the DOJ in 2013.

Source: Indian Express August 11, 2016 21:00 UTC